Evidence map›Paper›PMID 37605408›Full record

ReviewCurrent pharmaceutical biotechnology2024

Recent Advances in Biomedical Nanotechnology Related to Natural Products.

Qing Xia, Tingting Liang, Yue Zhou, Jun Liu, Yue Tang, Feila Liu

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current pharmaceutical biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Qing XiaSchool of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing, China.
Tingting LiangSchool of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing, China.
Yue ZhouSchool of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing, China.
Jun LiuSchool of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing, China.
Yue TangSchool of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing, China.
Feila LiuSchool of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing, China.ORCID 0000-0002-1263-9341
Chongqing University of Technology · CN

Funding

Chongqing University of Technology Science Research Startup Fund 2019ZD120
6 · The paper itself

Abstract

Natural product processing via nanotechnology has opened the door to innovative and significant applications in medical fields. On one hand, plants-derived bioactive ingredients such as phenols, pentacyclic triterpenes and flavonoids exhibit significant pharmacological activities, on another hand, most of them are hydrophobic in nature, posing challenges to their use. To overcome this issue, nanoencapsulation technology is employed to encapsulate these lipophilic compounds and enhance their bioavailability. In this regard, various nano-sized vehicles, including degradable functional polymer organic compounds, mesoporous silicon or carbon materials, offer superior stability and retention for bioactive ingredients against decomposition and loss during delivery as well as sustained release. On the other hand, some naturally occurring polymers, lipids and even microorganisms, which constitute a significant portion of Earth's biomass, show promising potential for biomedical applications as well. Through nano-processing, these natural products can be developed into nano-delivery systems with desirable characteristics for encapsulation a wide range of bioactive components and therapeutic agents, facilitating in vivo drug transport. Beyond the presentation of the most recent nanoencapsulation and nano-processing advancements with formulations mainly based on natural products, this review emphasizes the importance of their physicochemical properties at the nanoscale and their potential in disease therapy.

Indexed as

Biological ProductsNanotechnologyAnimalsDrug Delivery SystemsHumansNanoparticlesBiological Productsbioavailability.biomedicinenano-delivery systemnanoencapsulationnano-processingNatural products

Identifiers

PMID37605408
OpenAlexW4386045761

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.